NCT06610500

Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 20 (actual)
• Sponsor: Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Clozapine is a drug that requires regular and diligent hematological monitoring throughout its use. This follow-up is, in France, framed by a compulsory paper format of the blood count follow-up notebook for each patient. Due to the multiplicity of the different modes of transmission of the different documents necessary for compliance with the regulations for the prescription, dispensing and administration of clozapine, we decided to carry out a current inventory in the department of Loire with respect for the latter. The main objective of this study is to assess the rate of non-compliance in circuits of prescription, dispensing and administration of clozapine by sending a questionnaire on habits of prescriptions, dispensing and administration of health professionals (psychiatrists, pharmacists), and by sending a questionnaire to the patients treated by clozapine.

Conditions

• Schizophrenia
• Agranulocytosis

Interventions

Type	Name	Description
OTHER	Questionnaires	Questionnaires investigating the prescription and dispensing of clozapine.

Timeline

• Start date: 2023-05-16
• Primary completion: 2023-09-12
• Completion: 2023-09-12
• First posted: 2024-09-24
• Last updated: 2024-09-24

Locations

1 site across 1 country: France